The Antioxidant Effects of Isorhamnetin Contribute to Inhibit COX-2 Expression in Response to Inflammation: A Potential Role of HO-1
Authors:
- 13 December 2013
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 37 (3) , 712-722
Abstract
Previously, we reported that isorhamnentin, a 3′-O-methylated metabolite of quercetin, reduced inducible nitric oxide synthase (iNOS) expression and NO production. The present study further investigated the underlying mechanism of anti-inflammatory and antioxidant effects of isorhamnentin. Administration of isorhamnetin decreased the number of cyclooxygenase-2 (COX-2) positive cells in rats with carrageenan-induced paw edema. Isorhamnetin also suppressed lipopolysaccharide (LPS)-induced expression of COX-2 in cells. It is well known that LPS-induced reactive oxygen species (ROS) production leads to COX-2 induction. Isorhamnetin decreased LPS-induced ROS production and apoptosis. In addition, the basal expression of heme oxygenase-1 (HO-1) was increased by isorhamnetin treatment in agreement with the increase in nuclear translocation of NF-E2-related factor-2 (Nrf2), an essential transcription factor for the regulation of HO-1 expression. Moreover, pretreatment of tin protoporphyrin IX (SnPP), a chemical inhibitor of HO-1, reversed the ability of isothamnetin to inhibit COX-2 expression. These results demonstrate that induction of HO-1 by isorhamnetin leads to a reduction in ROS production and its antioxidant property might contribute to the inhibition of COX-2 expression in response to inflammation.Keywords
This publication has 50 references indexed in Scilit:
- Inhibitory Effects of Traditional Herbal Formula Pyungwi-San on Inflammatory ResponseIn VitroandIn VivoEvidence-Based Complementary and Alternative Medicine, 2013
- Bojesodok-eum, a Herbal Prescription, Ameliorates Acute Inflammation in Association with the Inhibition of NF-B-Mediated Nitric Oxide and ProInflammatory Cytokine ProductionEvidence-Based Complementary and Alternative Medicine, 2012
- Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targetsNature Reviews Drug Discovery, 2011
- Regulation of cyclooxygenase‐2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA‐binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen‐activated protein kinasesBritish Journal of Pharmacology, 2011
- MyD88 is a mediator for the activation of Nrf2Biochemical and Biophysical Research Communications, 2011
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Carbon monoxide donors or heme oxygenase-1 (HO-1) overexpression blocks interleukin-18-mediated NF-κB–PTEN-dependent human cardiac endothelial cell deathFree Radical Biology and Medicine, 2008
- Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid raftsJournal of Experimental Medicine, 2006
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Eicosanoids and the blood vessel wall.Circulation, 1984